(NasdaqGM:CCLD),(NasdaqGM:CCLDP),(NasdaqGM:CCLDO), Company to highlight AI innovation, strategic acquisitions, and continued growth momentum SOMERSET, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology solutions, announced today its participation in the ThinkEquity Conference, taking place October 30, 2025, at the Mandarin Oriental, New York City. […]

(NASDAQ:GSIT), SUNNYVALE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), developer of the Gemini (R) Associative Processing Unit (APU) for AI and high-performance parallel computing (HPPC) and a leading provider of high-performance memory solutions for networking, telecommunications and military markets, will announce financial results for its fiscal second quarter 2026 ended

SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, today announced that new preclinical data from its ACT-UP1 platform will be presented at two upcoming scientific conferences in November 2025. The data will be featured at the American Society of Nephrology (ASN) Kidney

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC's Biotech Footprint in Asia GlobeNewswire October 20, 2025 KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today announced that it has entered

(NASDAQ:PHAT), Management to host conference call on Thursday, October 30, 2025, at 8:00 am EDT FLORHAM PARK, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that it will host a live webcast at 8:00 am EDT

(NASDAQ:SSKN), HORSHAM, Penn., Oct. 20, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today provided an update on its competitive positioning and ongoing litigation against LaserOptek America Corp., LaserOptek Co. Ltd.

(CNSX:MAXM.CN),(Boerse Frankfurt – Freiverkehr:R7V),(TSX:ARIS), VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the appointment of Mr. Robert Eckford as a Technical Advisor to the Company. Robert Eckford is a seasoned mining executive and financial strategist with a strong

(NASDAQ:MBX), CARMEL, Ind., Oct. 20, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will

(NasdaqGM:CMRC),(NasdaqGM:BIGC),(NASDAQ:PYPL), AUSTIN, Texas, Oct. 20, 2025 (GLOBE NEWSWIRE) — Commerce, (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions and the parent company of BigCommerce, today announced a new embedded payment processing solution available exclusively to BigCommerce merchants. Powered by PayPal (Nasdaq: PYPL), BigCommerce Payments is slated for a U.S. launch in 2026, with international

(NASDAQ:ZSPC), SAN JOSE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning solutions for education, today announced that it has received approval from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its common stock from the Nasdaq